Copper complexes are promising
anticancer agents widely studied to overcome
tumor resistance to
metal-based anticancer drugs. Nevertheless,
copper complexes per se encounter drug resistance from time to time. Adenosine-5'-triphosphate (
ATP)-responsive nanoparticles containing a
copper complex CTND and
B-cell lymphoma 2 (Bcl-2)
small interfering RNA (
siRNA) were constructed to cope with the resistance of
cancer cells to the complex. CTND and
siRNA can be released from the nanoparticles in
cancer cells upon reacting with intracellular
ATP. The resistance of B16F10
melanoma cells to CTND was terminated by silencing the cellular Bcl-2 gene via RNA interference, and the therapeutic efficacy was significantly enhanced. The nanoparticles triggered a cellular autophagy that amplified the apoptotic signals, thus revealing a novel mechanism for antagonizing the resistance of
copper complexes. In view of the extensive association of Bcl-2
protein with
cancer resistance to chemotherapeutics, this strategy may be universally applicable for overcoming the ubiquitous drug resistance to metallodrugs.